Na-agba mbọ wulite obodo nwere akara aka zuru ụwa ọnụ!

Otu ụwa otu ọgụ
─Mmekọrịta mba ụwa iji wuo obodo zuru ụwa ọnụ nke akara aka na-anabata ihe ịma aka ọrịa COVID-19.

Striving to build a community with a global destiny1

Akwụkwọ akụkọ coronavirus na-agbasa gburugburu ụwa ebutela ọgba aghara COVID-19 zuru ụwa ọnụ na-aga n'ihu.Akwụkwọ akụkọ coronavirus enweghị oke, ọ nweghị obodo a ga-azọpụta n'ọgụ a megide COVID-19.Na nzaghachi maka ọrịa COVID-19 a zuru ụwa ọnụ, Liming Bio-Products Corp na-enye onyinye iji kwado ọdịmma nke obodo anyị zuru ụwa ọnụ.

Ụwa anyị na-eche mmetụta na-enwetụbeghị ụdị ya nke ọrịa ọrịa coronavirus 2019 (COVID-19).Ka ọ dị ugbu a, ọ nweghị ọgwụ dị mma maka ọgwụgwọ ọrịa a.Agbanyeghị, emepụtara ọtụtụ nyocha nyocha maka nchọpụta COVID-19.Nnwale ndị a dabere na usoro molekụla ma ọ bụ serological iji chọpụta akwụkwọ akụkọ coronavirus kpọmkwem nucleic acid ma ọ bụ ihe mgbochi biomarkers.Ka COVID-19 erutela ọnọdụ ọrịa na-efe efe, nchọpụta mmalite nke ọrịa coronavirus ọhụrụ dị oke mkpa n'ịtụle mgbasa nke nje a na ịnwe ya, mana nnwale zuru oke maka iji ụwa niile emebeghị.Anyị ga-amata ule enwere ike iji maka nyocha, nyocha na nleba anya nke ọrịa COVID-19, yana kedu oke ha.Ọ dị ezigbo mkpa ka esi eji ngwa sayensị ndị a eme ihe nke ọma yana nyere aka chọpụta na ịchịkwa mpụta nke ọrịa a na-agbasa ngwa ngwa na nke siri ike.

Ebumnuche nke nchọpụta nke akwụkwọ akụkọ coronavirus bụ iji chọpụta ma onye nwere ọrịa COVID-19 ma ọ bụ onye na-ebu asymptotic nke nwere ike gbasaa nje a na-agbachi nkịtị, iji nye ozi dị mkpa iji duzie mkpebi maka ọgwụgwọ ụlọ ọgwụ.Nnyocha ndị gara aga egosila na 70% nke mkpebi ụlọ ọgwụ na-adabere na nsonaazụ ule.Mgbe a na-eji ụzọ nchọpụta dị iche iche, ihe a chọrọ nke ngwa reagent nchọpụta dịkwa iche.

Striving to build a community with a global destiny2

Onyonyo 1

Foto 1:Eserese na-egosi usoro dị mkpa nke ọkwa biomarker izugbe n'oge a na-ahụkarị ọrịa COVID-19.X-axis na-egosi ọnụọgụ ụbọchị nke ọrịa, na Y-axis na-egosi ibu nje, ntinye nke antigens, na ntinye nke ọgwụ nje na oge dị iche iche.Antibody na-ezo aka na ọgwụ mgbochi IgM na IgG.A na-eji ma RT-PCR na nchọpụta antigen iji chọpụta ọnụnọ ma ọ bụ enweghị akwụkwọ akụkọ coronavirus, nke bụ ihe akaebe kpọmkwem maka nchọpụta onye ọrịa n'oge.N'ime otu izu nke ọrịa nje, nchọpụta PCR, ma ọ bụ nchọpụta antigen ka ahọrọ.Mgbe ọrịa coronavirus ọhụrụ ahụ gasịrị ihe dị ka ụbọchị 7, mgbochi IgM megide akwụkwọ akụkọ coronavirus ejiri nwayọọ nwayọọ na-abawanye n'ọbara onye ọrịa, mana ogologo oge ịdị adị dị mkpụmkpụ, na itinye uche ya na-ebelata ngwa ngwa.N'ụzọ dị iche, mgbochi IgG megide nje a na-apụta ma emechaa, ọ na-abụkarị ihe dịka ụbọchị iri na anọ ka nje virus butere ya.Ntinye uche IgG ji nwayọọ nwayọọ na-abawanye, ọ na-adịkwa ogologo oge n'ime ọbara.Ya mere, ọ bụrụ na achọpụtara IgM n'ọbara onye ọrịa, ọ pụtara na nje virus ebutela n'oge na-adịbeghị anya, nke bụ akara nrịanrịa nke mbụ.Mgbe achọpụtara mgbochi IgG n'ime ọbara onye ọrịa, ọ pụtara na nje virus adịla oge.A na-akpọkwa ya ọrịa mbubreyo ma ọ bụ ọrịa mbụ.A na-ahụkarị ya na ndị ọrịa nọ na oge mgbake.

Ihe biomarkers nke novel coronavirus
Akwụkwọ akụkọ coronavirus bụ nje RNA, nke mejupụtara protein na acid nucleic.Nje virus na-awakpo ahụ mmadụ (mmadụ), na-abanye n'ime sel site na njikọ saịtị kwekọrọ ACE2, ma megharịa n'ime sel ndị ọbịa, na-eme ka usoro ahụ ji alụso ọrịa ọgụ na-anabata ndị na-awakpo mba ọzọ wee mepụta ọgwụ mgbochi ụfọdụ.Ya mere, vial nucleic acid na antigens, na ọgwụ mgbochi ụfọdụ megide coronavirus akwụkwọ akụkọ nwere ike iji usoro ihe eji eme ihe dị ka ndị na-ahụ maka biomarkers maka nchọpụta coronavirus ọhụrụ.Maka nchọpụta nucleic acid, teknụzụ RT-PCR bụ ihe a na-ejikarị eme ihe, ebe a na-ejikarị usoro serological maka ịchọpụta ọgwụ mgbochi ọrịa coronavirus ọhụrụ.Ugbu a, enwere ụzọ nnwale dị iche iche anyị nwere ike ịhọrọ maka ịnwale ọrịa COVID-19 [1].

Ụkpụrụ bụ isi nke ụzọ nnwale maka coronavirus ọhụrụ
Ọtụtụ ule nyocha maka COVID_19 dị ugbu a, yana ngwa nnwale ndị ọzọ na-enweta nkwado n'okpuru ikike iji ihe mberede kwa ụbọchị.Agbanyeghi na mmepe ule ohuru a na-aputa na otutu aha na uzo di iche iche, ule COVID_19 niile di ugbu a dabere na teknụzụ abuo: nchọpụta nucleic acid maka nje RNA na serological immunoassays nke na-achọpụta ọgwụ mgbochi nje (IgM na IgG).

01. Nchọpụta Nucleic acid
Reverse transcription-polymerase chain reaction (RT-PCR), loop-mediated isothermal amplification (LAMP), na usoro ọgbọ na-abịa (NGS) bụ usoro nucleic acid a na-ahụkarị maka nchọpụta coronavirus RNA ọhụrụ.RT-PCR bụ ụdị nnwale mbụ maka COVID-19, nke ma Healthtù Ahụ Ike (wa (WHO) na Centerlọ Ọrụ Maka Nchịkwa na Mgbochi Ọrịa US (CDC) kwadoro.

02.Serological antibody nchọpụta
Antibody bụ protein nchebe emepụtara n'ahụ mmadụ maka nzaghachi nje virus.IgM bụ ụdị mgbochi mbụ ebe IgG bụ ụdị mgbochi ọzọ.A na-enyocha ihe nlele ọbara ma ọ bụ plasma maka ọnụnọ nke ụdị IgM na IgG dị iche iche nke mgbochi maka nyocha nke nnukwu na usoro ịgbagha nke ọrịa COVID-19.Ụzọ nchọpụta ihe mgbochi ndị a gụnyere colloidal gold immunochromatography assay, latex ma ọ bụ fluorescent microsphere immunochromatography, enzyme-linked immunosorbent assay (ELISA), na chemiluminescence assay.

03.Viral antigen nchọpụta
Antigen bụ ihe owuwu na nje virus nke ahụ mmadụ ghọtara nke na-akpalite usoro nchebe ahụ ji alụso ọrịa ọgụ mepụta ọgwụ mgbochi iji kpochapụ nje ahụ n'ọbara na anụ ahụ.Enwere ike ịche ma chọpụta antigen viral dị na nje ahụ site na iji immunoassay.Dị ka nje RNA viral, nje antigens dịkwa na traktị iku ume nke ndị butere ọrịa ma enwere ike iji ya chọpụta nnukwu oge nke ọrịa COVID-19.Ya mere, a na-atụkarị aro ka ị nakọta ụdị iku ume elu dị ka saliva, nasopharyngeal na oropharyngeal swabs, sputum ukwara miri emi, bronchoalveolar lavage fluid(BALF) maka nyocha mbụ antigen.

Nhọrọ nke usoro nnwale maka novel coronavirus
Ịhọrọ usoro nnwale gụnyere ọtụtụ ihe, gụnyere ntọala ụlọ ọgwụ, njikwa mma nnwale, oge ntụgharị, ụgwọ nnwale, ụzọ nnakọta, ihe ndị ọrụ ụlọ nyocha chọrọ, akụrụngwa na akụrụngwa chọrọ.Nchọpụta nke nucleic acids ma ọ bụ nje antigens bụ iji nye ihe akaebe na-egosi ọnụnọ nke nje ma gosi na nchoputa nke ọrịa coronavirus ọhụrụ.Agbanyeghị na enwere ọtụtụ ụzọ maka nchọpụta antigen, nchọpụta ha chọpụtara nke coronavirus akwụkwọ akụkọ dị ala karịa nke nkwalite RT-PCR.Nnwale mgbochi ọrịa bụ nchọpụta ọgwụ mgbochi nje a na-emepụta n'ime ahụ mmadụ, nke na-adịte aka n'oge, a naghị ejikarị ya eme nchọpụta n'oge n'oge nnukwu ọrịa nje.Ntọala ụlọ ọgwụ maka ngwa nchọpụta nwere ike ịdịgasị iche, na saịtị nchịkọta ihe nlele nwekwara ike ịdị iche.Maka nchọpụta viral nucleic acid na antigens, ọ dị mkpa ka achịkọta ihe atụ ahụ na traktị iku ume ebe nje ahụ dị, dị ka nasopharyngeal swabs, oropharyngeal swabs, sputum, ma ọ bụ bronchoalveolar lavage fluid (BALF).Maka nchọpụta dabere na ihe mgbochi, ọ dị mkpa ka a chịkọta ihe nleba anya ọbara ma nyochaa ya maka ọnụnọ nke mgbochi nje a kapịrị ọnụ (IgM/IgG).Agbanyeghị, nsonaazụ nnwale antibody na nucleic acid nwere ike ịkwado ibe ha.Dịka ọmụmaatụ, mgbe nsonaazụ nnwale bụ nucleic acid-negative, IgM-negative mana IgG-positive, nsonaazụ ndị a na-egosi na onye ọrịa anaghị ebu nje ugbu a, mana agbakeela ya na ọrịa coronavirus ọhụrụ.[2]

Uru na ọghọm dị na nyocha coronavirus ọhụrụ
N'ime usoro nyocha na ọgwụgwọ ọgwụgwọ maka novel Coronavirus pneumonia (Trial Version7) (nke National Health Commission & State Administration of Traditional Chinese Medicine weputara na Machị 3, 2020), a na-eji nnwale nucleic acid dị ka usoro ọkọlọtọ ọla edo maka nyocha nke akwụkwọ akụkọ ahụ. Ọrịa coronavirus, ebe a na-ahụtakwa nnwale mgbochi dị ka otu n'ime ụzọ nkwenye maka nyocha ahụ.

Striving to build a community with a global destiny3

Nchọpụta pathogenic na serological
(1) Ihe nchoputa nke oria: Enwere ike ichota novel coronavirus nucleic acid na nasopharyngeal swabs, sputum, secretions traktị iku ume ala, ọbara, nsị na ụdị ndị ọzọ site na iji ụzọ RT-PCRand/ma ọ bụ NGS.Ọ bụ ihe ziri ezi ma ọ bụrụ na enwetara ihe nlere anya site na traktị iku ume ala (sputum ma ọ bụ mmịpụta ikuku).Ekwesịrị ịnyefe ihe nlere anya maka nnwale ozugbo enwere ike ịnakọtachara.
(2) Nchọpụta serological: NCP nje kpọmkwem IgM ga-achọpụta ihe dị ka ụbọchị 3-5 mgbe mmalite;IgG na-erute titration nke opekata mpe okpukpu anọ n'oge nnabata ma e jiri ya tụnyere nnukwu oge.

Agbanyeghị, nhọrọ nke ụzọ nnwale dabere na mpaghara mpaghara, ụkpụrụ ahụike na ntọala ụlọ ọgwụ.Na USA, NIH nyere ntuziaka ọgwụgwọ Coronavirus Ọrịa 2019 (COVID-19) (Saịtị emelitere: Eprel 21,2020) na FDA nyere amụma maka Nnwale nyocha maka Ọrịa Coronavirus-2019 n'oge Mberede Ahụike Ọha (ewepụtara na Machị 16,2020). ), nke ahọpụtara ule serological nke ọgwụ mgbochi IgM/IgG naanị dị ka ule nyocha.

Ụzọ nchọpụta Nucleic Acid
RT_PCR bụ nnwale nucleic acid nwere mmetụta nke ukwuu emebere iji chọpụta ma coronavirus RNA noro nọ na akụkụ iku ume ma ọ bụ ihe atụ ọzọ.Nsonaazụ ule PCR dị mma pụtara ọnụnọ coronavirus RNA ọhụrụ na nlele iji gosi na ọrịa COVID-19.Nsonaazụ ule PCR na-adịghị mma apụtaghị enweghị ọrịa nje n'ihi na ọ nwere ike imetụta àgwà adịghị mma ma ọ bụ oge ọrịa n'oge mgbake, wdg.Ọ bụ ezie na RT-PCR bụ ule nwere mmetụta nke ukwuu, ọ nwere ọtụtụ ihe ndọghachi azụ.Nnwale RT-PCR nwere ike na-arụ ọrụ siri ike ma na-ewe oge, dabere na ịdị elu nke nlele ahụ.Nke a nwere ike ịbụ ihe ịma aka n'ihi na ọnụọgụ nje RNA ọ bụghị naanị na-adịgasị iche n'etiti ndị ọrịa dị iche iche kamakwa ọ nwere ike ịdịgasị iche n'ime otu onye ọrịa ahụ dabere na oge a na-anakọta ihe nlele yana usoro ọrịa ma ọ bụ mmalite nke mgbaàmà ụlọ ọgwụ.Ịchọta coronavirus ọhụrụ ahụ chọrọ ụdịdị dị elu nwere oke RNA viral na-emebibeghị.
Nnwale RT-PCR nwere ike inye nsonaazụ na-ezighi ezi (adịghị adịgboroja) maka ụfọdụ ndị ọrịa nwere ọrịa COVID-19.Dị ka anyị si mara, saịtị ndị bụ isi na-efe efe nke akwụkwọ akụkọ coronavirus dị na ngụgụ na akụkụ akụkụ iku ume nke ala, dị ka alveoli na bronchi.Ya mere, ụdị sputum sitere na ụkwara miri emi ma ọ bụ bronchoalveolar lavage fluid (BALF) weere na ọ nwere mmetụta kachasị elu maka nchọpụta nje.Otú ọ dị, na omume ụlọ ọgwụ, a na-anakọtakarị ihe nlele site na akụkụ iku ume elu site na iji nasopharyngeal ma ọ bụ oropharyngeal swabs.Ịnakọta ụdịdị ndị a abụghị naanị ahụ iru ala maka ndị ọrịa kamakwa ọ na-achọkwa ndị ọrụ zụrụ azụ pụrụ iche.Iji mee ka nlele ahụ ghara ịkpa ike ma ọ bụ dị mfe, n'ọnọdụ ụfọdụ, enwere ike inye ndị ọrịa ahụ swab ọnụ wee kwe ka ha were nlele sitere na mucosa buccal ma ọ bụ ire na-asụ onwe ha.Enweghị nje RNA zuru oke, RT-qPCR nwere ike weghachi nsonaazụ ule na-adịghị mma.Na mpaghara Hubei, China, RT-PCR uche na nchọpụta mbụ ka akọọrọ naanị ihe dịka 30% -50%, yana nkezi nke 40%.Ọnụ ọgụgụ dị elu nke ụgha-adịghị mma yikarịrị ka ọ bụ nlere ezughi oke.

Na mgbakwunye, ule RT-PCR chọrọ ndị ọrụ a zụrụ nke ọma ka ha rụọ usoro mmịpụta RNA siri ike yana usoro nkwalite PCR.Ọ na-achọkwa ọkwa dị elu nke nchebe biosafety, ụlọ nyocha pụrụ iche, yana ngwa PCR dị adị.Na china, a ga-eme ule RT-PCR maka nchọpụta COVID-19 na ụlọ nyocha biosafety 2 (BSL-2), yana nchedo ndị ọrụ site na iji usoro biosafety 3 (BSL-3).N'okpuru ihe ndị a, site na mbido Jenụwarị ruo mbido February 2020, ikike nke ụlọ nyocha China Wuhan CDC nwere ike ịchọpụta narị ikpe ole na ole kwa ụbọchị.Dị ka ọ na-adịkarị, nke a agaghị abụ nsogbu mgbe ị na-anwale ọrịa ndị ọzọ na-efe efe.Agbanyeghị, mgbe a na-emeso ọrịa na-efe efe zuru ụwa ọnụ dịka COVID-19 nwere ike ịnwale nde mmadụ, RT-PCR na-aghọ okwu dị oke egwu n'ihi ihe ọ chọrọ maka akụrụngwa ụlọ nyocha pụrụ iche ma ọ bụ akụrụngwa teknụzụ.Ọdịmma ndị a nwere ike igbochi RT-PCR ka eji mee ihe dị mma maka nyocha, yana nwekwara ike bute igbu oge na akụkọ nke nsonaazụ ule.

Usoro nchọpụta mgbochi ọrịa serological
Site na ọganihu ọrịa a na-aga n'ihu, karịsịa na etiti etiti na njedebe oge, ọnụọgụ nchọpụta mgbochi dị elu nke ukwuu.Nnyocha e mere na ụlọ ọgwụ Wuhan Central South gosiri na ọnụọgụ nchọpụta mmadụ nwere ike iru karịa 90% n'ime izu nke atọ nke ọrịa COVID-19.Ọzọkwa, ọgwụ mgbochi bụ ngwaahịa nke nzaghachi mgbochi mmadụ megide coronavirus ọhụrụ.Nnwale mgbochi mmadụ na-enye ọtụtụ uru karịa RT-PCR.Nke mbụ, ọgwụ mgbochi serological na-anwale ngwa ngwa yana ngwa ngwa.Enwere ike iji ule mgbaba n'akụkụ mgbochi mmadụ maka nlebara anya iji wepụta nsonaazụ n'ime nkeji iri na ise.Nke abuo, ebumnuche nyocha nke serological achọpụtara bụ mgbochi, nke amaara na ọ kwụsiri ike karịa nje virus RNA.N'oge nchịkọta, mbugharị, nchekwa na nnwale, ihe nlere anya maka nnwale mgbochi mmadụ na-adịkarị kwụsiri ike karịa ụdị maka RT-PCR.Nke atọ, n'ihi na ihe mgbochi na-ekesa nke ọma na mgbasa ọbara, enwere obere mgbanwe nlele ma e jiri ya tụnyere ule nucleic acid.Olu nlele achọrọ maka nnwale mgbochi ahụ pere mpe.Dịka ọmụmaatụ, 10 microliter nke ọbara mkpịrị mkpịsị aka zuru oke maka ojiji na nnwale mpụta nke mgbochi ahụ.

Na mkpokọta, a na-ahọrọ nnwale mgbochi mmadụ ka ọ bụrụ ngwa mgbakwunye maka nchọpụta nucleic acid iji meziwanye ọnụọgụ nchọpụta coronavirus n'oge ọmụmụ ọrịa.Mgbe a na-eji ọgwụ mgbochi ahụ yana ule nucleic acid, ọ nwere ike ịbawanye nzizi nyocha maka nyocha nke COVID19 site na ibelata nsonaazụ ụgha na nke adịgboroja.Ntuziaka ọrụ ugbu a anaghị akwado iji ụdị ule abụọ dị iche iche dị ka usoro nchọpụta nọọrọ onwe ya mana ekwesịrị iji ya dị ka usoro jikọtara ọnụ.[2]

Striving to build a community with a global destiny4

Foto 2:Nkọwa ziri ezi nke nucleic acid na nsonaazụ nnwale antibody maka nchọpụta nke ọrịa coronavirus ọhụrụ

China's Experience At Novel Coronavirus Pneumonia's Diagnosis3

Ọgụgụ 3:Liming Bio-Products Co., Ltd. - Akwụkwọ akụkọ coronavirus IgM/IgG antibody dual fast test Kit (StrongStep)®SARS-CoV-2 IgM/IgG Antibody Rapid Test, Latex Immunochromatography)

China's Experience At Novel Coronavirus Pneumonia's Diagnosis1

Foto 4:Liming Bio-Products Co., Ltd. - StrongStep®Novel Coronavirus (SARS-CoV-2) Ngwa PCR Real-Time Multiplex (nchọpụta maka mkpụrụ ndụ ihe nketa atọ, usoro nyocha fluorescent).

Mara:Ngwa PCR a dị njikere nke ukwuu dị n'ụdị lyophilized (usoro ịsa oyi) maka nchekwa ogologo oge.Enwere ike ibufe ngwa ahụ ma chekwaa ya na ụlọ okpomọkụ ma kwụsie ike maka otu afọ.Ọ bụla tube nke premix nwere ihe niile reagents dị mkpa maka PCR amplification, gụnyere Reverse-transcriptase, Taq polymerase, primers, probes, na dNTPs substrates.Users nwere ike nanị reconstitute mix site na-agbakwụnye PCR-ọkwa mmiri tinyere template wee buo ibu. n'elu ngwa PCR iji mee nkwalite ahụ.

Na nzaghachi na ntiwapụ nke ọrịa coronavirus ọhụrụ, Liming Bio-Products Co., Ltd arụ ọrụ ngwa ngwa ịmepụta ngwa nyocha abụọ iji mee ka ụlọ nyocha ụlọ ọgwụ na ahụike ọha nwee ike ịchọpụta ọrịa COVID-19 ngwa ngwa.Ngwa ndị a dabara nke ọma maka ojiji maka nyocha buru ibu na mba na mpaghara ebe akwụkwọ akụkọ coronavirus na-agbasa ngwa ngwa, yana maka ịnye nyocha na nkwenye maka ọrịa COVID-19.Ngwa ndị a bụ maka ojiji naanị n'okpuru ikike iji ihe mberede amara ọkwa (PEUA).Nnwale bụ naanị na ụlọ nyocha enwetara n'okpuru iwu gọọmentị mba ma ọ bụ mpaghara.

Usoro nchọpụta antigen
1. A na-ekewa nchọpụta antigen viral n'otu ụdị nke nchọpụta kpọmkwem dị ka nchọpụta nucleic acid.Ụzọ nchọpụta ndị a kpọmkwem na-achọ ihe akaebe nke nje nje nje na ihe nlele ahụ ma nwee ike iji ya mee nchọpụta nkwenye.Agbanyeghị, mmepe nke ngwa nchọpụta antigen chọrọ ogo dị elu nke ọgwụ mgbochi monoclonal nwere njikọ siri ike na nghọta dị elu nke nwere ike ịmata na ijide nje nje.Ọ na-ewekarị ihe karịrị ọnwa isii iji họrọ na bulie ọgwụ mgbochi monoclonal dabara adaba maka iji na nkwadebe nke ngwa nchọpụta antigen.

2. Ugbu a, ndị reagents maka kpọmkwem nchọpụta nke novel coronavirus ka nọ na nyocha na mmepe ogbo.Ya mere, ọ nweghị ngwa nchọpụta antigen akwadola n'ụlọ ọgwụ yana dị na azụmaahịa.Ọ bụ ezie na a kọbuola ya na ụlọ ọrụ nyocha na Shenzhen ewepụtala ngwa nchọpụta antigen na nyocha ụlọ ọgwụ na Spain, enweghị ike ịkwado ntụkwasị obi nke nyocha na izi ezi n'ihi ọnụnọ nke reagent àgwà okwu.Ruo ugbu a, NMPA (nke bụbu China FDA) akwadobeghị ngwa nchọpụta antigen maka ojiji ụlọ ọgwụ.N'ikpeazụ, e mepụtala ụzọ nchọpụta dị iche iche.Usoro ọ bụla nwere uru na njedebe ya.Enwere ike iji nsonaazụ sitere na ụzọ dị iche iche maka nkwenye na imeju.

3. Imepụta ngwa nyocha COVID-19 dị mma dabere na njikarịcha n'oge nyocha na mmepe.Ụgwọ nke ụlọ ọrụ Liming Bio-Product Co., Ltd.A na-achọ ngwa ule iji zute ụkpụrụ nrụpụta siri ike na njikwa mma iji hụ na ha na-enye ọkwa kachasị elu nke arụmọrụ yana nkwụsi ike.Ndị ọkà mmụta sayensị nọ na Liming Bio-Product Co., Ltd. nwere ihe karịrị afọ iri abụọ ahụmahụ n'ichepụta, ịnwale, na ịkwalite ngwa nyocha in vitro iji hụ na arụmọrụ kachasị elu na nyocha nyocha.

N'oge ọrịa COVID-19 na-efe efe, gọọmentị China chere nnukwu mkpa maka ihe mgbochi ọrịa na ebe mba ụwa.On April 5, na pịa ogbako nke State Council Joint Mgbochi na Control Mechanism "Ime ka Quality Management nke Medical Materials na Regulating Order nke Market", Jiang Fan, a mbụ-larịị onye nyocha nke Foreign Trade Department nke Ministry nke Azụmahịa, kwuru, sị, "Na-esote, anyị ga-elekwasị anya na mbọ anyị n'akụkụ abụọ, nke mbụ, iji mee ka nkwado nke ọgwụ ndị ọzọ dị mkpa nke mba ụwa chọrọ, yana kwa, iji melite njikwa, nhazi na njikwa ngwaahịa. Anyị ga-enye aka China ijikọ ọnụ na-anabata ọrịa na-efe efe zuru ụwa ọnụ na iwulite obodo nwere ọdịnihu nke ihe a kpọrọ mmadụ.

Striving to build a community with a global destiny6
Striving to build a community with a global destiny7
Striving to build a community with a global destiny8

Foto 5:Liming Bio-Products Co., Ltd akwụkwọ akụkọ coronavirus reagent enwetala asambodo ndebanye aha CE nke EU.
Akwụkwọ nkwanye ugwu

Striving to build a community with a global destiny11
Striving to build a community with a global destiny10

Houshenshan
Ọgụgụ 6. Liming Bio-Products Co., Ltd kwadoro ụlọ ọgwụ Wuhan Vulcan (HouShenShan) Mountain iji lụso ọrịa COVID-19 ọgụ wee nye ya asambodo nsọpụrụ nke Wuhan Red Cross.Hospitallọ ọgwụ ugwu Wuhan Vulcan bụ ụlọ ọgwụ ama ama na China nke na-ahụ maka ọgwụgwọ nke ndị ọrịa COVID-19 siri ike.

Ka akwụkwọ akụkọ coronavirus ntiwapụ na-aga n'ihu na-agbasa gburugburu ụwa, Nanjing Liming Bio-Products Co., Ltd na-agbago ịkwado ma nyere obodo niile aka na teknụzụ ọhụrụ anyị iji lụso iyi egwu zuru ụwa ọnụ a na-enwetụbeghị ụdị ya ọgụ.Nnwale ngwa ngwa nke ọrịa COVID-19 bụ akụkụ dị oke mkpa n'igbo ihe iyi egwu a.Anyị na-aga n'ihu na-enye aka n'ụzọ dị ịrịba ama site n'inye usoro nyocha dị elu n'aka ndị ọrụ ahụike n'ihu ka ndị mmadụ wee nweta nsonaazụ ule dị oke mkpa ha chọrọ.Mgbalị Liming Bio-products Co., Ltd. na-eme n'ọgụ megide ọrịa COVID-19 bụ inye aka na teknụzụ, ahụmịhe na nka anyị n'obodo mba ụwa maka iwu obodo nke akara aka.

 

Ogologo Pịa ~ Nyochaa wee soro anyị
Email: sales@limingbio.com
Weebụsaịtị: https://limingbio.com


Oge nzipu: Mee-01-2020